GHOSH ANIRVAN (Chief Executive Officer) sold 0.9% of their position (680.00 shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2024ACC: 0000950170-24-011232
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-680.00
Net shares
Net seller
$1.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
680.00 disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−680.00
Price / share
$1.71
Trade value
$1.16K
% of position
0.9%
2/2/2024
79.43K→78.75K
Total
Net shares
−680.00
Net value
-$1.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 2/2/2024 | S · Sale | −680.00 | $1.71 | $1.16K | 0.9% | 79.43K | 78.75K |
| Total | −680.00 | -$1.16K | ||||||
Derivative Transactions0
No derivative transactions reported